News Briefing channel feed – Endpoints News

News Briefing channel feed

Vertex beefs up gene-editing work with new discovery pact; Verrica shares jump on molluscum drug data; J&J's inks two deals

7 years ago

Stealth Bio posts plans for $86M IPO; Sanofi out-licenses drug for neuroendocrine-related disease

7 years ago

G1 touts PhII cancer data, but shares tank on placebo results; Merck bags another approved indication for Keytruda

7 years ago

Vivek Ramaswamy bags option rights on Daiichi’s pipeline drugs; Achillion drops a lead program; Ziopharm creates new development company for China

7 years ago

Novo helps birth startup advancing an AstraZeneca castoff with $15M; Japan's Fuji Pharma wagers $50M on Alvotech's biosimilars

7 years ago

Vertex CFO Thomas Graney exits abruptly; Eli Lilly touts a head-to-head win over Humira

7 years ago

Lilly, Incyte's baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

7 years ago

Art Krieg moves from CEO post to CSO at Checkmate; Indivior breathes sigh of relief after court ruling

7 years ago

Amgen enlists Entera in a drug discovery pact; Boehringer brings out the budget ax

7 years ago

Shanghai Junshi Biosciences next to test HKEX listing; With one eye on Sage, Marinus reports prelim PPD data

7 years ago

Sanofi will eliminate 670 jobs in France; Moderna gets FDA orphan status for preclinical asset

7 years ago

Mallinckrodt to spin off generics business; BeyondSpring ready to submit approval for lead drug in China

7 years ago

UK sets up vaccines centre as Brexit looms; Shanghai's Elpiscience bags $35M in Series B

7 years ago

Gilead's HIV drug Descovy wins China's endorsement; Revance investors smile as frown lines drug succeeds pivotal studies

7 years ago

GAO pokes holes in FDA's orphan designation process; Takeda Traditionalists make one more appeal against Shire buyout ahead of vote

7 years ago

Boehringer axes biosimilar development outside US; MacroGenics, China's Zai Labs join forces to develop I/O treatments

7 years ago

Incyte hires Janssen exec as CSO Huber moves to Third Rock; Synthorx set terms for $100M IPO

7 years ago

BeiGene inks $60M licensing, research pacts with Zymeworks; Merck, AbbVie, Amgen back neuro upstart

7 years ago

GW Pharma shares surge on positive PhIII followup; Illumina leads $18M round for Stilla's DNA tech

7 years ago

Roivant joins forces with Korea's iNtRON Bio to fight superbugs; Evotec inks deal to leverage AI to develop drugs

7 years ago

Eli Lilly vet takes helm at Brickell Biotech; Stemline's Elzonris secures speedy EU review

7 years ago

Fortress Biotech sells brokerage firm following Reuters exposé; Tracon contends with another setback in brain cancer

7 years ago

Takeda family preps for a last-stand vote against Shire buyout; Eli Lilly reportedly shopping drug portfolio in China

7 years ago

Centrexion delays IPO; Exelixis makes $40M as Cabometyx wins EU nod

7 years ago

First page Previous page 53 54 555657 58 59 Next page Last page